About 40% of 600 people with conditions like cancer and arthritis, whose treatments can interfere with immunity, had insufficient responses to standard vaccine regimens, according to the study published Tuesday in preprint form by the
Countries including the U.S. have begun rolling out third shots for people whose immune systems are weakened either by disease or immune-blunting therapies. The U.S. also released plans last week ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
